Lung disease in premature neonates: Radiologic-pathologic correlation

Radiographics

Volumn 25, Issue 4, 2005, Pages 1047-1073

  Agrons, Geoffrey A ^a,b   Courtney, Sherry E ^c   Stocker, J Thomas ^d   Markowitz, Richard I ^e  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LUNG DYSPLASIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATHOLOGY; PREMATURITY; RADIOGRAPHY; REVIEW;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 23944523818     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/rg.254055019     Document Type: Article

References (128)

1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. Natl Vital Stat Rep 2003; 52:1-113.
2. Blondel B, Kogan MD, Alexander GR, et al. The impact of the increasing number of multiple births on the rates of preterm birth and low birthv weight: an international study. Am J Public Health 2002; 92:1323-1330.
3. Langston C. Prenatal lung growth and pulmonary hypoplasia. In: Stocker JT, ed. Pediatric pulmonary disease. Washington, DC: Hemisphere, 1989.
4. Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA, ed. Lung growth and development. New York, NY: Marcel Dekker, 1997; 1-35.
5. Tschanz SA, Burri PH. Postnatal lung development and its impairment by glucocorticoids. Pediatr Pulmonol Suppl 1997; 16:247-249.
6. Agrons GA, Harty MP. Lung disease in premature neonates: impact of new treatments and technologies. Semin Roentgenol 1998; 33:101-116.
7. Whitsett JA, Pryhuber GS, Rice WR, et al. Acute respiratory disorders. In: Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology: pathophysiology and management of the newborn. 4th ed. Philadelphia, Pa: Lippincott, 1994; 429-452.
8. Newman B, Kuhn JP, Kramer SS, Carcillo JA. Congenital surfactant protein B deficiency: emphasis on imaging. Pediatr Radiol 2001; 31:327-331.
9. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46:641-643.
10. Massaro GD, Massaro D. Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation. Ann Rev Physiol 1996; 58:73-92.
11. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995; 152:640-646.
12. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160:1333-1346.
13. Yoder BA, Siler-Khodr T, Winter VT, Coalson JJ. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000; 162:1867-1876.
14. Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs: disordered respiratory tract development. Am J Respir Crit Care Med 1999; 159:945-958.
15. Jobe AH, Newnham J, Willet K, Sly P, Ikegami M. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids. Pediatrics 1998; 102:1116-1125.
16. Pinkerton KE, Willet KE, Peake JL, Sly PD, Jobe AH, Ikegami M. Prenatal glucocorticoid and T4 effects on lung morphology in preterm lambs. Am J Respir Crit Care Med 1997; 156:624-630.
17. Bunton TE, Plopper CG. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol 1984; 148:203-215.
18. Tyson JE, Kennedy K, Broyles S, Rosenfeld CR. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival? Pediatrics 1995; 95:534-538.
19. Friedman SA, Schiff E, Kao L, Sibai BM. Neonatal outcome after preterm delivery for pre-eclampsia. Am J Obstet Gynecol 1995; 172: 1785-1788; discussion 1788-1792.
20. Hallak M, Bottoms SF. Accelerated pulmonary maturation from preterm premature rupture of membranes: a myth. Am J Obstet Gynecol 1993; 169:1045-1049.
21. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 1995; 273:413-418.
22. Cleveland RH. A radiologic update on medical diseases of the newborn chest. Pediatr Radiol 1995; 25:631-637.
23. Stocker JT. The respiratory tract. In: Stocker JT, Dehner LP, eds. Pediatric pathology. Philadelphia, Pa: Lippincott, 1992; 505-573.
24. Swischuk LE, John SD. Immature lung problems: can our nomenclature be more specific? AJR Am J Roentgenol 1996; 166:917-918.
25. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50:515-525.
26. Garite TJ, Rumney PJ, Briggs GG, et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992; 166:646-651.
27. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97:11-25.
28. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists: Number 38, September 2002. Perinatal care at the threshold of viability. Obstet Gynecol 2002; 100: 617-624.
29. Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 2001; 98:144-150.
30. Jobe AH, Ikegami M. Beyond the consensus conference for antenatal glucocorticoids. In: Frantz I, ed. Neonatal respiratory diseases. Newtown, Pa: Associates in Medical Marketing, 2000; 1-8.
31. Farrell EE, Silver RK, Kimberlin LV, Wolf ES, Dusik JM. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants. Am J Obstet Gynecol 1989; 161:628-633.
32. Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997; 100:31-38.
33. Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1993; 123:757-766.
34. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group I. J Pediatr 1991; 118:277-284.
35. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 1985; 76:145-153.
36. Hoekstra RE, Jackson JC, Myers TF, et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991; 88:10-18.
37. Hudak ML, Martin DJ, Egan EA, et al. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics 1997; 100:39-50.
38. Kattwinkel J, Bloom BT, Delmore P, et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993; 92:90-98.
39. Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991; 324:865-871.
40. Liechty EA, Donovan E, Purohit D, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 1991; 88:19-28.
41. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. American Exosurf Neonatal Study Group I and Canadian Exosurf Neonatal Study Group. N Engl J Med 1991; 325:1696-1703.
42. Long W, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. American Exosurf Neonatal Study Group I. J Pediatr 1991; 118:595-605.
43. Merritt TA, Hallman M, Berry C, et al. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr 1991; 118:581-594.
44. Repka MX, Hudak ML, Parsa CF, Tielsch JM. Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology 1992; 99:531-536.
45. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 1994; 330:1476-1480.
46. Shapiro DL, Notter RH, Morin FC 3rd, et al. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics 1985; 76:593-599.
47. Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996; 97:1-6.
48. Schimmel MS. Respiratory distress syndrome: therapeutic aspects. Pediatr Radiol 1995; 25:641-642.
49. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001; 2:CD000144.
50. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; 2:CD000510.
51. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284:1333-1340.
52. Towers HM, Wung JT. Rationing ventilatory support for the newborn with respiratory distress. Pediatr Radiol 1995; 25:638-640.
53. Schimmel MS, Hammerman C. Early nasal continuous positive airway pressure with or without prophylactic surfactant therapy in the premature infant with respiratory distress syndrome. Pediatr Radiol 2000; 30:713-714.
54. Clark RH, Gerstmann DR, Jobe AH, Moffitt ST, Slutsky AS, Yoder BA. Lung injury in neonates: causes, strategies for prevention, and long-term consequences. J Pediatr 2001; 139:478-486.
55. Courtney SE, Durand DJ, Asselin JM, et al. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 2002; 347: 643-652.
56. Johnson AH, Peacock JL, Greenough A, et al. High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 2002; 347:633-642.
57. Klein MD, Whittlesey GC. Extracorporeal membrane oxygenation. Pediatr Clin North Am 1994; 41:365-384.
58. Wood BP. The newborn chest. Radiol Clin North Am 1993; 31:667-676.
59. Edwards DK, Hilton SV, Merritt TA, Hallman M, Mannino F, Boynton BR. Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology 1985; 157:329-334.
60. Bick U, Muller-Leisse C, Troger J, et al. Therapeutic use of surfactant in neonatal respiratory distress syndrome: correlation between pulmonary x-ray changes and clinical data. Pediatr Radiol 1992; 22:169-173.
61. Clarke EA, Siegle RL, Gong AK. Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants. AJR Am J Roentgenol 1989; 153:799-802.
62. Wood BP, Sinkin RA, Kendig JW, Notter RH, Shapiro DL. Exogenous lung surfactant: effect on radiographic appearance in premature infants. Radiology 1987; 165:11-13.
63. Levine D, Edwards DK, 3rd, Merritt TA. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings. AJR Am J Roentgenol 1991; 157:371-374.
64. Soll RF, Horbar JD, Griscom NT, Barth RA, Lucey JF, Taeusch HW. Radiographic findings associated with surfactant treatment. Am J Perinatol 1991; 8:114-118.
65. Dinger J, Schwarze R, Rupprecht E. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome. Pediatr Radiol 1997; 27:26-31.
66. Slama M, Andre C, Huon C, Antoun H, Adamsbaum C. Radiological analysis of hyaline membrane disease after exogenous surfactant treatment. Pediatr Radiol 1999; 29:56-60.
67. van Houten J, Long W, Mullett M, et al. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. American Exosurf Neonatal Study Group I and Canadian Exosurf Neonatal Study Group. J Pediatr 1992; 120(suppl 2, pt 2):S40-S44.
68. Krauss AN, Klain DB, Auld PA. Chronic pulmonary insufficiency of prematurity (CPIP). Pediatrics 1975; 55:55-58.
69. Edwards DK, Jacob J, Gluck L. The immature lung: radiographic appearance, course, and complications. AJR Am J Roentgenol 1980; 135:659-666.
70. Wilson MG, Mikity VG. A new form of respiratory disease in premature infants. Am J Dis Child 1960; 99:489-499.
71. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276:357-368.
72. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723-1729.
73. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001; 18:1-9.
74. Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979; 95:819-823.
75. Northway WH Jr. Bronchopulmonary dysplasia: thirty-three years later. Pediatr Pulmonol 2001; 23(suppl):5-7.
76. Farrell PA, Fiascone JM. Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician. Curr Probl Pediatr 1997; 27:129-163.
77. Engle WA. Age terminology during the perinatal period. Pediatrics 2004; 114:1362-1364.
78. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82:527-532.
79. Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998; 179:1632-1639.
80. Nievas FF, Chernick V. Bronchopulmonary dysplasia (chronic lung disease of infancy): an update for the pediatrician. Clin Pediatr (Phila) 2002; 41:77-85.
81. O'Brodovich HM, Mellins RB. Bronchopulmonary dysplasia: unresolved neonatal acute lung injury. Am Rev Respir Dis 1985; 132:694-709.
82. Davis JM, Rosenfeld WN. Chronic lung disease. In: Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology: pathophysiology and management of the newborn. Philadelphia, Pa: Lippincott, 1994; 453-477.
83. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia: current issues. Pediatr Clin North Am 1994; 41:277-315.
84. Stocker JT. Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol 1986; 17:943-961.
85. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29:710-717.
86. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97:210-215.
87. Lyon A. Chronic lung disease of prematurity: the role of intra-uterine infection. Eur J Pediatr 2000; 159:798-802.
88. Theilen U, Lyon AJ, Fitzgerald T, Hendry GM, Keeling JW. Infection with Ureaplasma urealyticum: is there a specific clinical and radiological course in the preterm infant? Arch Dis Child Fetal Neonatal Ed 2004; Mar 89(2):F163-F167.
89. Kotecha S, Hodge R, Schaber JA, Miralles R, Silverman M, Grant WD. Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. Pediatr Res 2004; 55:61-68.
90. Hodgman JE. Relationship between Wilson-Mikity syndrome and the new bronchopulmonary dysplasia. Pediatrics 2003; 112:1414-1415.
91. Swischuk LE, Shetty BP, John SD. The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems? Pediatr Radiol 1996; 26:508-511.
92. Weinstein MR, Peters ME, Sadek M, Palta M. A new radiographic scoring system for bronchopulmonary dysplasia. Newborn Lung Project. Pediatr Pulmonol 1994; 18:284-289.
93. Yuksel B, Greenough A, Karani J. Prediction of chronic lung disease from the chest radiograph appearance at 7 days of age. Acta Paediatr 1993; 82:944-947.
94. Yuksel B, Greenough A, Karani J. Comparison of a subjective and a quantitative assessment of the neonatal chest radiograph. Br J Radiol 1992; 65: 1083-1085.
95. Maconochie I, Greenough A, Yuksel B, Page A, Karani J. A chest radiograph scoring system to predict chronic oxygen dependency in low birth weight infants. Early Hum Dev 1991; 26:37-43.
96. Toce SS, Farrell PM, Leavitt LA, Samuels DP, Edwards DK. Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child 1984; 138:581-585.
97. Giffin F, Greenough A, Karani J. Chest radiograph appearance at 24 h of age: prediction of chronic oxygen dependency. Br J Radiol 1995; 68:248-251.
98. Noack G, Mortensson W, Robertson B, Nilsson R. Correlations between radiological and cytological findings in early development of bronchopulmonary dysplasia. Eur J Pediatr 1993; 152:1024-1029.
99. Hansen TW, Wallach M, Dey AN, Boivin P, Vohr B, Oh W. Prognostic value of clinical and radiological status on day 28 of life for subsequent course in very low birthweight (<1,500g) babies with bronchopulmonary dysplasia. Pediatr Pulmonol 1993; 15:327-331.
100. Kothari NA, Kramer SS. Bronchial diseases and lung aeration in children. J Thorac Imaging 2001; 16:207-223.
101. Howling SJ, Northway WH Jr, Hansell DM, Moss RB, Ward S, Muller NL. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. AJR Am J Roentgenol 2000; 174:1323-1326.
102. Oppenheim C, Mamou-Mani T, Sayegh N, de Blic J, Scheinmann P, Lallemand D. Bronchopulmonary dysplasia: value of CT in identifying pulmonary sequelae. AJR Am J Roentgenol 1994; 163:169-172.
103. Aquino SL, Schechter MS, Chiles C, Ablin DS, Chipps B, Webb WR. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. AJR Am J Roentgenol 1999; 173:963-967.
104. Greenough A. Prevention and management of neonatal chronic lung disease: short-term gains, but long-term losses. Neonat Respir Dis 2000; 10:1-8.
105. Northway WH Jr, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323:1793-1799.
106. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001; 1:1.
107. Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109:330-338.
108. Kao LC, Durand DJ, Phillips BL, Nickerson BG. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J Pediatr 1987; 111:439-444.
109. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349:2099-2107.
110. Effmann E, Martin LD. Lymphatic air embolism: a proposed hypothesis. Pediatr Radiol 1995; 25(suppl 1):S228-S229.
111. Booth TN, Allen BA, Royal SA. Lymphatic air embolism: a new hypothesis regarding the pathogenesis of neonatal systemic air embolism. Pediatr Radiol 1995; 25(suppl 1):S220-S227.
112. Boothroyd AE, Barson AJ. Pulmonary interstitial emphysema: a radiological and pathological correlation. Pediatr Radiol 1988; 18:194-199.
113. Campbell RE. Intrapulmonary interstitial emphysema: a complication of hyaline membrane disease. Am J Roentgenol Radium Ther Nucl Med 1970; 110:449-456.
114. Williams DW, Merten DF, Effmann EL, Scatliff JH. Ventilator-induced pulmonary pseudocysts in preterm neonates. AJR Am J Roentgenol 1988; 150:885-887.
115. Stocker J, Madewell J. Persistent interstitial pulmonary emphysema: another complication of the respiratory distress syndrome. Pediatrics 1977; 59:847-857.
116. Jabra AA, Fishman EK, Shehata BM, Perlman EJ. Localized persistent pulmonary interstitial emphysema: CT findings with radiographic-pathologic correlation. AJR Am J Roentgenol 1997; 169:1381-1384.
117. Donnelly LF, Frush DP. Localized radiolucent chest lesions in neonates: causes and differentiation. AJR Am J Roentgenol 1999; 172:1651-1658.
118. Magilner AD, Capitanio MA, Werthemier I, Burko H. Persistent localized intrapulmonary interstitial emphysema: an observation in three infants. Radiology 1974; 111:379-384.
119. Donnelly LF, Lucaya J, Ozelame V, et al. CT findings and temporal course of persistent pulmonary interstitial emphysema in neonates: a multi-institutional study. AJR Am J Roentgenol 2003; 180:1129-1133.
120. Gurakan B, Tarcan A, Arda IS, Coskun M. Persistent pulmonary interstitial emphysema in an unventilated neonate. Pediatr Pulmonol 2002; 34:409-411.
121. Swischuk LE. Respiratory system. In: Swischuk LE, ed. Imaging of the newborn, infant, and young child. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2004; 1-170.
122. Markowitz RI. The anterior junction line: a radiographic sign of bilateral pneumothorax in neonates. Radiology 1988; 167:717-719.
123. O'Keeffe FN, Swischuk LE, Stansberry SD. Mediastinal pseudomass caused by compression of the thymus in neonates with anterior pneumothorax. AJR Am J Roentgenol 1991; 156:145-148.
124. Moseley JE. Loculated pneumomediastinum in the newborn: a thymic "spinnaker sail" sign. Radiology 1960; 75:788-790.
125. Levin B. The continuous diaphragm sign: a newly-recognized sign of pneumomediastinum. Clin Radiol 1973; 24:337-338.
126. Greenough A, Dimitriou G, Alvares BR, Karani J. Routine daily chest radiographs in ventilated, very low birth weight infants. Eur J Pediatr 2001; 160:147-149.
127. Cohen RS, Smith DW, Stevenson DK, Moskowitz PS, Graham CB. Lateral decubitus position as therapy for persistent focal pulmonary interstitial emphysema in neonates: a preliminary report. J Pediatr 1984; 104:441-443.
128. Seibert JJ, Dahlmann K, Hill DE. Selective left bronchial intubation for the treatment of pulmonary pseudocyst in the very premature infant. J Pediatr Surg 1984; 19:198-199.